Home›Search›Molecular Therapy Oncology

Molecular Therapy Oncology

Cell Press · United States · Est. 1998

ISSN2950-3299eISSN2950-3299

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total75

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.716

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.943

Total Works

391

Total Citations

1,009

2yr Mean Citedness

2.59

Free JIF alternative

Aims & Scope✦ Compiled from public sources

Molecular Therapy Oncology is an international journal focusing on the development and testing of cancer therapies in pre-clinical and clinical settings. It provides a forum for work in biologic cancer therapies, including viral therapies.

AI-compiled from public web sources · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Slow · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1998

Annual Volume~ 107 articles / year

StatusActive (last: 2026)

Total Publications391

OA Since2023

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~22 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✗ No

📦 Long-term Preservation

Koninklijke BibliotheekPorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

9/12 · 75%

✅

Do you know the journal / publisher?

Cell Press

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2950-3299 / 2950-3299

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Koninklijke Bibliotheek, Portico, CLOCKSS

❌

Plagiarism detection in place?

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

1998

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1

Molecular MedicineQ1

OncologyQ1

Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

Medicine, Research & ExperimentalOncology

Scopus Categories

Pharmacology (medical)Cancer ResearchOncologyMolecular Medicine

Research Topics (OpenAlex)

CAR-T cell therapy researchVirus-based gene therapy researchImmunotherapy and Immune ResponsesImmune Cell Function and InteractionCancer Research and TreatmentsViral Infectious Diseases and Gene Expression in InsectsCancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies ResearchRNA Interference and Gene DeliveryCRISPR and Genetic Engineering